Documents
Safety and efficacy after switch to a saquinavir-containing antiretroviral regimen in protease inhibitor pretreated HIV-positive patients
Stephan C, Jaeger H, Carganico A, Knecht G, Lutz T, Mayr C, Mosthaf Fa, Koeppe S, Tappe A, Wellmann E, Knechten H, Mueller M, Wolfe
Documents
Savoirs
Safety and efficacy after switch to a saquinavir-containing antiretroviral regimen in protease inhibitor pretreated HIV-positive patients
Stephan C, Jaeger H, Carganico A, Knecht G, Lutz T, Mayr C, Mosthaf Fa, Koeppe S, Tappe A, Wellmann E, Knechten H, Mueller M, Wolfe
8 pages
English
Documents
Changes in lipid profiles after switching to a protease inhibitor-containing cART - unfavourable effect of fosamprenavir in obese patients
Gyalrong-Steur M, Bogner Jr, Seybold, Seybold U
Documents
The rainbow cohort: 96 week follow-up of saquinavir-containing regimens in previously antiretroviral therapy (ART)-naïve and pre-treated but protease inhibitor (PI)- naïve hiv-infected patients
Wellmann E, Knechten H, Stephan C, Mosthaf Fa, Jaeger H, Carganico A, Lutz T, Schewe K, Mayr C, Wolfe, Tappe A
Documents
Savoirs
The rainbow cohort: 96 week follow-up of saquinavir-containing regimens in previously antiretroviral therapy (ART)-naïve and pre-treated but protease inhibitor (PI)- naïve hiv-infected patients
Wellmann E, Knechten H, Stephan C, Mosthaf Fa, Jaeger H, Carganico A, Lutz T, Schewe K, Mayr C, Wolfe, Tappe A
8 pages
English
Collection
{{collectionTitle}}
Collection
{{collectionTitle}}
Collection
{{collectionTitle}}
{{productCategoryLabel}}
{{productTitle}}
{{productAuthors}}
{{productCategoryLabel}}
{{productThemeLabel}}
{{productTitle}}
{{productAuthors}}
{{productPages}}
{{productLanguageIsoCode}}